Woodcock, Marks Recusals From COVID-19 Product Reviews ‘Protect FDA’s Reputation’

In the Pink Sheet, Catalyst’s Nancy Myers commends how “Marks and Woodcock recognize they can’t be both referee and player” as they recuse themselves from reviewing COVID-19 products while working on Operation Warp Speed. She says, “The recusal is a step to protect the FDA’s reputation so people see it as an unbiased and scientifically based organization.”

Read the full article here (subscription required).